Opendata, web and dolomites


Development and validation of an innovative nutritional solution to fight muscle atrophy during human space flights, application of the acquired knowledge to prevent muscle degeneration down on earth

Total Cost €


EC-Contrib. €






 ASTROCIT project word cloud

Explore the words cloud of the ASTROCIT project. It provides you a very rough idea of what is the project "ASTROCIT" about.

flights    astronauts    innovative    validate    protocol    hardly    giving    muscle    quality    strategy    surgery    question    astronaut    underwent    feasibility    compounds    preventive    instance    huge    autonomy    missions    astrocit    lasting    human    first    nutrition    space    business    commercializing    therapeutic    someone    performance    scientific    expertise    mass    amino    seize    atrophy    deliverable    backing    ease    satisfactory    consolidating    solutions    reducing    galenics    proven    formulation    ageing    industrial    50    acids    plan    muscular    severely    bettering    compliancy    weightlessness    routine    financial    ip    medical    injured    efficiency    revolutionize    people    hitherto    earth    aged    bioavailability    answer    collecting    older    quantify    fight    effect    prevent    person    solution    cared    serious    spending    accessing    gerontologists    thereby    exercise    public    degeneration    citrage    data    health    commercially    physicians    lose    unseen    physiotherapists    benefit    combination    mitigate    opportunity    nutraceutical    risks    life    clinical    diet    updated    immobilization   

Project "ASTROCIT" data sheet

The following table provides information about the project.


Organization address
postcode: 94019
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.6. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Space)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-03-01   to  2016-08-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CITRAGE FR (CRETEIL) coordinator 50˙000.00


 Project objective

Question: What is the common factor between an astronaut, an older person and someone who just underwent a serious surgery? Answer: Muscle atrophy. During long missions for instance, astronauts can lose up to 50% of their muscle mass severely affecting their performance and health. The only commercially available solutions hardly able to mitigate the effect of weightlessness, ageing and immobilization are exercise and diet but they are not satisfactory in terms of efficiency, ease-of-use, bioavailability, compliancy or scientific backing. AstroCIT’s objective is to develop and validate an innovative nutraceutical to fight muscle loss during human space flights and prevent muscular degeneration on earth. It will revolutionize how muscle atrophy is cared for by giving space physicians, gerontologists and physiotherapists an effective preventive and therapeutic solution, thereby enabling astronauts to be more operational, bettering quality of life in space, improving autonomy of aged or injured people and reducing public spending. This new nutraceutical is based on CITRAGE’s and its partners’ long lasting expertise in developing and commercializing amino acids based products applied to the combination of a proven and a hitherto unseen compounds. During phase 1, CITRAGE will scale-up the project by (a) defining the best formulation and galenics for the product, (b) accessing data generated by other research projects in the field of nutrition and muscle atrophy, (c) collecting medical and financial data to further quantify the technology’s benefit and its risks, (d) defining the protocol of a EU clinical study to be implemented in phase 2 and (e) consolidating the IP strategy. The main deliverable will be an updated business plan enabling CITRAGE to seize this huge business opportunity of further exploiting their know-how in space and down on earth. This feasibility study is an essential first step before routine use and industrial production.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ASTROCIT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ASTROCIT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.6.;H2020-EU.2.3.1.)

DIVERT (2017)

Diamond Integrated Vacuum Electronics for more Robust Tubes

Read More  

ReadyToSail (2016)


Read More  

HELIUM (2015)

High European Laboratory for Institutes, Universities and Markets

Read More